CVE-2026-21974
Last modified
CVE-2026-21974 is a medium-severity vulnerability rated 5.3/10 on the CVSS scale. Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. EPSS estimates a 0.22% chance of exploitation in the next 30 days.
Description
Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Oracle | Life Sciences Central Designer | 7.0.1.0 |
References
- https://www.oracle.com/security-alerts/cpujan2026.htmlVendor Advisory
Timeline
- Published
- Last Modified
- Status
- Analyzed
Frequently Asked Questions
What is CVE-2026-21974?
How severe is CVE-2026-21974?
How do I fix CVE-2026-21974?
Are you affected by CVE-2026-21974?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST